Skip to main content

Type 2 Inflammation Learning Library

Featured Video

Steven Feldman
Rapid Refresh
01/13/2025
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology

Atopic dermatitis
News
01/17/2025
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Steven Feldman
Rapid Refresh
01/13/2025
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Atopic dermatitis
News
01/07/2025
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
08/14/2024
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch...
08/14/2024
APP Institute Dermatology
Atopic dermatitis
News
01/17/2025
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Steven Feldman
Rapid Refresh
01/13/2025
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Joy Wan
Clinical Pearls
01/10/2025
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic...
01/10/2025
APP Institute Dermatology
Atopic dermatitis
News
01/07/2025
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
Roxana Daneshjou, MD, PhD
Clinical Pearls
09/12/2024
Explore an AI imaging app pilot study with Dr Roxana Daneshjou,.
Explore an AI imaging app pilot study with Dr Roxana Daneshjou,.
Explore an AI imaging app pilot...
09/12/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
08/14/2024
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch...
08/14/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
08/14/2024
Explore the basic mechanisms of itch with Dr Brian Kim.
Explore the basic mechanisms of itch with Dr Brian Kim.
Explore the basic mechanisms of...
08/14/2024
APP Institute Dermatology
Amy Baum-Jones, PA-C
Rapid Refresh
06/18/2024
Become versed in the basics of vitiligo with Amy Baum-Jones, PA-C.
Become versed in the basics of vitiligo with Amy Baum-Jones, PA-C.
Become versed in the basics of...
06/18/2024
APP Institute Dermatology
Lakshi Aldredge, NP
APP Perspectives
06/11/2024
Editorial Advisory Board Member Lakshi Aldredge, NP, shares what's in store for our new APP Institute Dermatology microlearning site.
Editorial Advisory Board Member Lakshi Aldredge, NP, shares what's in store for our new APP Institute Dermatology microlearning site.
Editorial Advisory Board Member...
06/11/2024
APP Institute Dermatology

Videos

Steven Feldman
Rapid Refresh
01/13/2025
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
08/14/2024
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch...
08/14/2024
APP Institute Dermatology
Steven Feldman
Rapid Refresh
01/13/2025
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Joy Wan
Clinical Pearls
01/10/2025
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic...
01/10/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
Roxana Daneshjou, MD, PhD
Clinical Pearls
09/12/2024
Explore an AI imaging app pilot study with Dr Roxana Daneshjou,.
Explore an AI imaging app pilot study with Dr Roxana Daneshjou,.
Explore an AI imaging app pilot...
09/12/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
08/14/2024
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch...
08/14/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
08/14/2024
Explore the basic mechanisms of itch with Dr Brian Kim.
Explore the basic mechanisms of itch with Dr Brian Kim.
Explore the basic mechanisms of...
08/14/2024
APP Institute Dermatology
Amy Baum-Jones, PA-C
Rapid Refresh
06/18/2024
Become versed in the basics of vitiligo with Amy Baum-Jones, PA-C.
Become versed in the basics of vitiligo with Amy Baum-Jones, PA-C.
Become versed in the basics of...
06/18/2024
APP Institute Dermatology
Lakshi Aldredge, NP
APP Perspectives
06/11/2024
Editorial Advisory Board Member Lakshi Aldredge, NP, shares what's in store for our new APP Institute Dermatology microlearning site.
Editorial Advisory Board Member Lakshi Aldredge, NP, shares what's in store for our new APP Institute Dermatology microlearning site.
Editorial Advisory Board Member...
06/11/2024
APP Institute Dermatology
test
Rapid Refresh
02/20/2024
Review the clinical features and epidemiology of prurigo nodularis with Dr Shawn Kwatra.
Review the clinical features and epidemiology of prurigo nodularis with Dr Shawn Kwatra.
Review the clinical features and...
02/20/2024
APP Institute Dermatology
Lakshi Aldredge
APP Perspectives
02/14/2024
Staff members are at the heart of the dermatology practice. Nurse practitioner Lakshi Aldredge and Dr Linda Stein Gold discuss how to recruit and retain exceptional staff.
Staff members are at the heart of the dermatology practice. Nurse practitioner Lakshi Aldredge and Dr Linda Stein Gold discuss how to recruit and retain exceptional staff.
Staff members are at the heart...
02/14/2024
APP Institute Dermatology

News

Atopic dermatitis
News
01/17/2025
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Atopic dermatitis
News
01/07/2025
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology
Atopic dermatitis
News
01/17/2025
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Atopic dermatitis
News
01/07/2025
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology